These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 8552282

  • 1. Glycogen synthase kinase-3 beta phosphorylates tau protein at multiple sites in intact cells.
    Sperber BR, Leight S, Goedert M, Lee VM.
    Neurosci Lett; 1995 Sep 08; 197(2):149-53. PubMed ID: 8552282
    [Abstract] [Full Text] [Related]

  • 2. Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells.
    Lovestone S, Reynolds CH, Latimer D, Davis DR, Anderton BH, Gallo JM, Hanger D, Mulot S, Marquardt B, Stabel S.
    Curr Biol; 1994 Dec 01; 4(12):1077-86. PubMed ID: 7704571
    [Abstract] [Full Text] [Related]

  • 3. Sites of phosphorylation in tau and factors affecting their regulation.
    Anderton BH, Betts J, Blackstock WP, Brion JP, Chapman S, Connell J, Dayanandan R, Gallo JM, Gibb G, Hanger DP, Hutton M, Kardalinou E, Leroy K, Lovestone S, Mack T, Reynolds CH, Van Slegtenhorst M.
    Biochem Soc Symp; 2001 Dec 01; (67):73-80. PubMed ID: 11447841
    [Abstract] [Full Text] [Related]

  • 4. Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta.
    Reynolds CH, Betts JC, Blackstock WP, Nebreda AR, Anderton BH.
    J Neurochem; 2000 Apr 01; 74(4):1587-95. PubMed ID: 10737616
    [Abstract] [Full Text] [Related]

  • 5. Glycogen synthase kinase 3 alteration in Alzheimer disease is related to neurofibrillary tangle formation.
    Baum L, Hansen L, Masliah E, Saitoh T.
    Mol Chem Neuropathol; 1996 Apr 01; 29(2-3):253-61. PubMed ID: 8971700
    [Abstract] [Full Text] [Related]

  • 6. Characterization of tau phosphorylation in glycogen synthase kinase-3beta and cyclin dependent kinase-5 activator (p23) transfected cells.
    Michel G, Mercken M, Murayama M, Noguchi K, Ishiguro K, Imahori K, Takashima A.
    Biochim Biophys Acta; 1998 Apr 10; 1380(2):177-82. PubMed ID: 9565682
    [Abstract] [Full Text] [Related]

  • 7. Physiology and pathology of tau protein kinases in relation to Alzheimer's disease.
    Imahori K, Uchida T.
    J Biochem; 1997 Feb 10; 121(2):179-88. PubMed ID: 9089387
    [Abstract] [Full Text] [Related]

  • 8. Tau phosphorylation in cells transfected with wild-type or an Alzheimer's disease mutant Presenilin 1.
    Irving NG, Miller CC.
    Neurosci Lett; 1997 Jan 31; 222(2):71-4. PubMed ID: 9111731
    [Abstract] [Full Text] [Related]

  • 9. The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bepsilon at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase.
    Woods YL, Cohen P, Becker W, Jakes R, Goedert M, Wang X, Proud CG.
    Biochem J; 2001 May 01; 355(Pt 3):609-15. PubMed ID: 11311121
    [Abstract] [Full Text] [Related]

  • 10. Site-specific phosphorylation of tau accompanied by activation of mitogen-activated protein kinase (MAPK) in brains of Niemann-Pick type C mice.
    Sawamura N, Gong JS, Garver WS, Heidenreich RA, Ninomiya H, Ohno K, Yanagisawa K, Michikawa M.
    J Biol Chem; 2001 Mar 30; 276(13):10314-9. PubMed ID: 11152466
    [Abstract] [Full Text] [Related]

  • 11. Glycogen synthase kinase 3 phosphorylates recombinant human tau protein at serine-262 in the presence of heparin (or tubulin).
    Moreno FJ, Medina M, Pérez M, Montejo de Garcini E, Avila J.
    FEBS Lett; 1995 Sep 18; 372(1):65-8. PubMed ID: 7556645
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation.
    Zheng-Fischhöfer Q, Biernat J, Mandelkow EM, Illenberger S, Godemann R, Mandelkow E.
    Eur J Biochem; 1998 Mar 15; 252(3):542-52. PubMed ID: 9546672
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cellular phosphorylation of tau by GSK-3 beta influences tau binding to microtubules and microtubule organisation.
    Wagner U, Utton M, Gallo JM, Miller CC.
    J Cell Sci; 1996 Jun 15; 109 ( Pt 6)():1537-43. PubMed ID: 8799840
    [Abstract] [Full Text] [Related]

  • 20. Reactivating kinase/p38 phosphorylates tau protein in vitro.
    Reynolds CH, Nebreda AR, Gibb GM, Utton MA, Anderton BH.
    J Neurochem; 1997 Jul 15; 69(1):191-8. PubMed ID: 9202310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.